While positive associations have been identified between several cardiometabolic risk factors in midlife and AD, with higher cardiac function [77] and body mass index (BMI) [78], independently of the APOE genotype, the mechanisms by which cardiovascular risk factors may mitigate the risk of AD in those at high polygenic risk have not been thoroughly described [79–81]. Here, APOE is linked to Alzheimer disease.